IFP Advisors’s Xenetic Biosciences XBIO Stock Holding History

IFP Advisors’s Portfolio XBIO Stock Details XBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$2K	–	3500
2021 Q3	$2K	Buy	+100	New	+$2.73K	﹤0.01%	2910

Other funds holding XBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

IFP Advisors's XBIO Position: Q4 2021 in Review

IFP Advisors sold out of Xenetic Biosciences (XBIO) in Q4 2021, closing a stake of 100 shares — an estimated $2K sold.

IFP Advisors first reported a position in XBIO in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 22 funds tracked by Wall St. Rank hold XBIO as of Q4 2021.

IFP Advisors reported no remaining Xenetic Biosciences position as of Q4 2021 after selling out during the quarter.
IFP Advisors sold 100 Xenetic Biosciences shares in Q4 2021, an estimated $2K.
IFP Advisors first reported a position in Xenetic Biosciences in Q3 2021 and held it in 1 quarter.
IFP Advisors's Xenetic Biosciences position peaked at $2K in Q3 2021.
22 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q4 2021.

Based on IFP Advisors's 13F filing for Q4 2021, filed 12 Jan 2022.